Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
Marcello Ciaccio, Giulia Bivona, Chiara BelliaDepartment of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo, ItalyAbstract: Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 the relationship between altered ho...
Main Authors: | Marcello Ciaccio, Giulia Bivona, Chiara Bellia |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-03-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/therapeutical-approach-to-plasma-homocysteine-and-cardiovascular-risk--a1296 |
Similar Items
-
Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01) -
Dietary influences on plasma homocysteine, a risk factor for cardiovascular disease
by: Ward, Mary
Published: (1998) -
Plasma Homocysteine and Oxidative Stress in Cardiovascular Disease
by: S. S. Moselhy, et al.
Published: (2003-01-01) -
HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
by: Jan Filipovský
Published: (2007-08-01) -
Homocysteine: cardiovascular risk factor in children and adolescents?
by: Adriana Amorim De Farias Leal, et al.
Published: (2013-12-01)